Asper Biotech has updated its Ashkenazi Jewish Diseases Test to include mutations in the BRCA1, BRCA2, and LCA5 genes that are common in the Ashkenazi Jewish population. Asper's test now detects up to 112 variants in 27 genes.
Asper Biotech recently introduced a number of new test panels targeted to mitochondrial diseases.
Asper Biotech recently launched a new carrier test to detect the most common mutations associated with autosomal recessive disorders that are overrepresented in the Hutterite population.
From its office in Tartu, Estonia, Asper Biotech continues to introduce new microarray-based tests related to reproductive health, oncology, and opthamalogy.
Asper Biotech recently launched a test for Leber hereditary optic neuropathy, or LHON, a disease characterized by optic nerve dysfunction that leads to painless, subacute loss of central vision.
Asper Biotech recently launched several new reprogenetic tests. The Tartu, Estonia-based firm uses arrayed primer extension to test fetal cells for specific genetic abnormalities.
By Justin PetroneThis story was originally posted Sept. 10
Asper Biotech has introduced array-based prenatal testing for fetuses with increased nuchal translucency but normal karyotype.
Ambry Genetics last week launched its CancerArray, an exon-focused, 180,000-probe array for comparative genomic hybridization.
Asper Biotech's Sensorineural Hearing Loss Test, Fujifilm's DMP-5005 Materials Printer, BioForce Nanosciences' ProCleaner Plus
Anagnostics' Hyborg System, Asper Biotech's Congenital Stationary Night Blindness Genetic Test
Cancer researcher Alan Rabson has died at 92, the New York Times reports.
As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.
In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.
The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.